menu
    • menu

    Company profile for Halozyme Therapeutics

    NEW Drugs in Dev: 24
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. Our research targets the extracellular matrix, an area outside the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, we have developed unique scientific expertise th...
    Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. Our research targets the extracellular matrix, an area outside the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, we have developed unique scientific expertise that allows us to pursue this target-rich environment for the development of future therapies. The company's research focuses primarily on human enzymes that alter the extracellular matrix.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Halozyme TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11388 Sorrento Valley Road San Diego, CA 92121
    Telephone
    Telephone
    858.794.8889
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://halozyme.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    India Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    India Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vertex Taps Halozyme In $15M Upfront Biologics Drug Delivery Deal
    Vertex Taps Halozyme In $15M Upfront Biologics Drug Delivery Deal

    07 Apr 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/vertex-taps-halozyme-and-its-recently-acquired-elektrofi-tech-15m-drug-delivery-deal

    FIERCE PHARMA
    07 Apr 2026
    Share Share
    Halozyme Appoints David Ramsay As Interim Chief Financial Officer
    Halozyme Appoints David Ramsay As Interim Chief Financial Officer

    12 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-appoints-david-ramsay-as-interim-chief-financial-officer-302711900.html

    PR NEWSWIRE
    12 Mar 2026
    Share Share
    Halozyme To Participate In Upcoming Investor Conferences
    Halozyme To Participate In Upcoming Investor Conferences

    25 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-to-participate-in-upcoming-investor-conferences-302696455.html

    PR NEWSWIRE
    25 Feb 2026
    Share Share
    Halozyme Hits Record $1.4B Revenue, Reaffirms 2026 Outlook
    Halozyme Hits Record $1.4B Revenue, Reaffirms 2026 Outlook

    17 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-reports-full-year-2025-record-revenue-of-1-4-billion-and-reiterates-strong-2026-financial-guidance-302689822.html

    PR NEWSWIRE
    17 Feb 2026
    Share Share
    Halozyme to Report Fourth Quarter and Full Year 2025
    Halozyme to Report Fourth Quarter and Full Year 2025

    10 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-to-report-fourth-quarter-and-full-year-2025-financial-and-operating-results-302684270.html

    PR NEWSWIRE
    10 Feb 2026
    Share Share
    Halozyme Boosts 2025 Revenue, 2026 Financial Outlook
    Halozyme Boosts 2025 Revenue, 2026 Financial Outlook

    28 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/halozyme-raises-2025-revenue-estimates-raises-2026-and-multi-year-financial-guidance-302672024.html

    PR NEWSWIRE
    28 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Halozyme Therapeutics and get a quotation

    Halozyme Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of ENHANZE DRUG PRODUCT bulk with DMF offered by Halozyme Therapeutics

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search